Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T13:25:20.528Z.
Calculation as of: 2026-10-06T13:25:20.528Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e485f36d7fb886f24af0c94a2bf1db7ebf50bc29bea95def6f96f714dad4fb70
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$1.11B
EBITDA Yield
N/A
TTM Avg
8.27%
3Y Avg
5.84%
5Y Avg
4.14%
Market Cap
$1.16B
EBITDA Yield
0.89%
TTM Avg
0.77%
3Y Avg
0.77%
5Y Avg
0.77%
Market Cap
$990.24M
EBITDA Yield
6.02%
TTM Avg
6.89%
3Y Avg
5.60%
5Y Avg
6.99%
Market Cap
$897.50M
EBITDA Yield
1.52%
TTM Avg
1.35%
3Y Avg
1.18%
5Y Avg
0.99%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arteris, Inc. (AIP) | $1.11B | N/A | N/A | N/A | N/A |
| ZoomInfo Technologies Inc. (GTM)vs › | $1.11B | N/A | 8.27% | 5.84% | 4.14% |
| Boost Run Inc. Class A Common Stock (BRUN)vs › | $1.16B | 0.89% | 0.77% | 0.77% | 0.77% |
| POET Technologies Inc. (POET)vs › | $1.03B | N/A | N/A | N/A | N/A |
| CEVA, Inc. (CEVA)vs › | $1.02B | N/A | 0.93% | 0.90% | 0.71% |
| Harmonic Inc. (HLIT)vs › | $1.22B | 6.22% | 5.70% | 4.97% | 4.34% |
| Rackspace Technology, Inc. (RXT)vs › | $990.24M | 6.02% | 6.89% | 5.60% | 6.99% |
| Aeva Technologies, Inc. (AEVA)vs › | $965.75M | N/A | N/A | N/A | N/A |
| Daily Journal Corporation (DJCO)vs › | $897.50M | 1.52% | 1.35% | 1.18% | 0.99% |
| Alpha and Omega Semiconductor Limited (AOSL)vs › | $867.96M | N/A | 4.00% | 6.02% | 9.91% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute